US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data

Loading...
Loading...
Pre-open movers
US stock futures traded higher in early pre-market trade. Data on weekly jobless claims and nonfarm business productivity for the fourth quarter will be released at 8:30 a.m. ET. Data on factory orders for January will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 24 points to 18,110.00, while the Standard & Poor's 500 index futures rose 2.70 points to 2,099.20. Futures for the Nasdaq 100 index climbed 7.75 points to 4,452.00.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index rising 0.54%, STOXX Europe 600 Index surging 0.55% and German DAX 30 index gaining 0.75%. French CAC 40 Index climbed 0.83% and London's FTSE 100 Index rose 0.37%. In Asian markets, Japan's Nikkei Stock Average rose 0.26%, Hong Kong's Hang Seng Index dropped 1.11%, China's Shanghai Composite Index slipped 0.95% and India's BSE Sensex rose 0.23%.
Broker Recommendation
Analysts at B Riley upgraded American Eagle Outfitters, Inc.
AEO
from Neutral to Buy and raised the price target from $15.00 to $20.00. American Eagle's shares climbed 7.69% to close at $15.96 yesterday.
Breaking news
  • Costco Wholesale Corp. COST reported stronger-than-expected earnings for the fiscal second quarter. To read the full news, click here.
  • Mallinckrodt plc MNK and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion. To read the full news, click here. Antero Resources Corporation AR announced today that it has commenced an underwritten public offering of 11,500,000 shares of the Company's common stock. To read the full news, click here.
  • AbbVie ABBV and Pharmacyclics PCYC today announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica® (ibrutinib), a highly effective treatment for hematologic malignancies. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsB RileyUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...